Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP285578.RAQzuPjVIFn4r30bnHKfbTeV4eY86m1Sto9K2YiyO0rH0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP285578.RAQzuPjVIFn4r30bnHKfbTeV4eY86m1Sto9K2YiyO0rH0130_assertion type Assertion NP285578.RAQzuPjVIFn4r30bnHKfbTeV4eY86m1Sto9K2YiyO0rH0130_head.
- NP285578.RAQzuPjVIFn4r30bnHKfbTeV4eY86m1Sto9K2YiyO0rH0130_assertion wasGeneratedBy ECO_0000203 NP285578.RAQzuPjVIFn4r30bnHKfbTeV4eY86m1Sto9K2YiyO0rH0130_provenance.
- NP285578.RAQzuPjVIFn4r30bnHKfbTeV4eY86m1Sto9K2YiyO0rH0130_assertion wasDerivedFrom befree-20140225 NP285578.RAQzuPjVIFn4r30bnHKfbTeV4eY86m1Sto9K2YiyO0rH0130_provenance.
- NP285578.RAQzuPjVIFn4r30bnHKfbTeV4eY86m1Sto9K2YiyO0rH0130_assertion SIO_000772 22351695 NP285578.RAQzuPjVIFn4r30bnHKfbTeV4eY86m1Sto9K2YiyO0rH0130_provenance.
- NP285578.RAQzuPjVIFn4r30bnHKfbTeV4eY86m1Sto9K2YiyO0rH0130_assertion evidence source_evidence_literature NP285578.RAQzuPjVIFn4r30bnHKfbTeV4eY86m1Sto9K2YiyO0rH0130_provenance.
- NP285578.RAQzuPjVIFn4r30bnHKfbTeV4eY86m1Sto9K2YiyO0rH0130_assertion description "[ON 01910.Na (Rigosertib), a multikinase phosphoinositide 3-kinase (PI3K) inhibitor, is entering phase III trials for myelodysplastic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP285578.RAQzuPjVIFn4r30bnHKfbTeV4eY86m1Sto9K2YiyO0rH0130_provenance.